The editors and compilers of this volume will find a smallish but appreciative audience for the publication of an account book from the business of Anthony Daffy, the well-known manufacturer and trader in what came to be famous as Daffy\'s Elixir. The account book, with entries for the years 1674--83, was found by Patrick Wallis, and he and David Boyd Haycock set about transcribing and annotating it under the aegis of the Wellcome Trust, one of the few patrons of studies in how the medical market developed during the early modern period. Much of this large market consisted of proprietary medicines---originally secret but, if successful, eventually much copied concoctions, often manufactured as a single product by people not trained as apothecaries or physicians, and therefore generally included under the umbrella of quackery. Similar markets for proprietary medicines have been described by Colin Jones for France, and by David Gentilcore and William Eamon for Italy and the transalpine areas. The manufacture and trade in these products were enabled, as is well known, by increased means of spreading information, above all through printed broadsides, by urbanization, and by a growth in disposable income---factors distinguishing the regional, and eventually national and overseas trade in these medicines from the preparation and sale of medicines by local lay healers, which they supplemented but never entirely displaced.

Continuous account books of this type are a rare although not unique find, and we need more of them in published form if historians are to develop a comparative profile of this market. Haycock and Wallis preface the accounts proper with an introduction laying out personae and the history and spread of the elixir. They meet the expectations of the reader hungry for a full narrative not as comprehensively as one would wish, but there is a large amount of data in the carefully annotated accounts themselves. For the ten-year period covered, the reader can extract prices, sales volumes, unit sizes, packaging, shipping routes, characteristics and location of debtors and creditors (mainly, but not exclusively, general merchants), kinship networks, accounting methods during a period of rapid mercantilistic growth, and much more. While medical historians may find the relative absence of recognized medical providers as direct purchasers of these nostrums proof of their status as quack medicines---secrecy, lack of institutional controls to ensure a modicum of manufacturing standards and safety---it might be well at this stage of research to remember that quackery is a relative term.

During the same period, many respectable physicians in Great Britain and continental Europe manufactured and sold their own secret nostrums, some with comparable acumen. Haycock and Wallis note that the known ingredients---a bowel stimulant and spirits---and effects of the elixir, were common to many medications of the time. If Daffy\'s Elixir continued to be sold into the late nineteenth century and even beyond, this was true also for the tonic of the venerable professor from Halle Friedrich Hoffmann. The business of Anthony Daffy and similar proprietary medicine makers was part of a general commercial model adopted twenty-five years later by the makers of the Halle Orphanage medications, who were fully credentialled physicians and Christian philanthropists. In turn, they established a similarly far-flung network of sales of not one universal nostrum but a whole inventory of preparations that were widely advertised without the blessing of traditional medical authorities. The term quackery continues to be in need of an update, therefore. Mr Daffy\'s accounts are a valuable contribution to an overdue assessment of the extent to which traditional medical practice and commercial pharmacy overlapped at the end of the early modern period.
